Anti-CD19-CAR-T-Zellen zur Behandlung des refraktären oder rezidivierenden DLBCL
Crossref DOI link: https://doi.org/10.1007/s15004-019-6554-5
Published Online: 2019-06-14
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kobold, Sebastian
Text and Data Mining valid from 2019-06-01
Version of Record valid from 2019-06-01
Article History
First Online: 14 June 2019